About Medicamen
Medicamen is a company based in Delhi (India) founded in 1993. The company has 376 employees as of March 31, 2024. Medicamen operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Delhi, India
- Employees 376 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medicamen Biotech Limited
-
Annual Revenue
$19.08 M (USD)-9.34as on Mar 31, 2025
-
Net Profit
$831.99 K (USD)-34.97as on Mar 31, 2025
-
EBITDA
$1.73 M (USD)-40.53as on Mar 31, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
376
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medicamen
Medicamen is a publicly listed company on the NSE with ticker symbol MEDICAMEQ in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Medicamen
Investments & Acquisitions by Medicamen
Financial Statements - Medicamen
Medicamen Comparisons
Competitors of Medicamen
Medicamen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
Latest news on Medicamen
Frequently Asked Questions about Medicamen
Medicamen was founded in 1993.
Medicamen is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Mar 31, 2024, the latest employee count at Medicamen is 376.
Annual revenue of Medicamen is $19.08M as on Mar 31, 2025.
Medicamen was established in 1993 in Delhi, India, within the pharmaceuticals sector. Finished formulations are developed and produced across two plants, including dedicated blocks for Beta-lactam products, non-Beta-lactam items, Cephalosporin, oral liquids, ORS, iron-folic acid tablets, ointments, and lotions. An in-house RD unit is utilized to standardize various formulations for multiple indications.
Medicamen's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Yes, Medicamen is publicly traded on NSE under the ticker symbol MEDICAMEQ.
The ticker symbol of Medicamen is MEDICAMEQ on NSE.